• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物洗脱微球经动脉化疗栓塞术后,中间值扩散加权成像检测残留肝细胞癌的诊断准确性

Diagnostic accuracy of intermediate -value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads.

作者信息

Hassan Ahmed E, Mostafa Radwa E, Nada Ayman, Elazab Mohamed S, Awad Ahmed Sayed, Hamed Ikram M

机构信息

Department of Diagnostic and Interventional Radiology, National Cancer Institute, Cairo University, Cairo, Egypt.

Department of Radiology, University of Missouri, USA.

出版信息

Indian J Radiol Imaging. 2019 Apr-Jun;29(2):195-200. doi: 10.4103/ijri.IJRI_383_18.

DOI:10.4103/ijri.IJRI_383_18
PMID:31367092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6639864/
Abstract

PURPOSE

To evaluate the role of diffusion-weighted magnetic resonance imaging (DW-MRI) in the detection of residual malignant tumor of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) with drug-eluting beads (DEBs).

SUBJECTS AND METHODS

Pre-contrast T1, T2, dynamic contrast-enhanced, and respiratory-triggered DW-MRI (b factor 0, 400, and 800 s/mm) were obtained in 60 patients with HCC who underwent tran-sarterial hepatic chemoembolization with DEBs. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the DW imaging images. Apparent diffusion coefficients (ADCs) were calculated searching for the optimal cut-off value using the receiver operating characteristic (ROC) curve.

RESULTS

DW-MRI had a sensitivity of 77.1%, a specificity of 60.7%, a PPV of 71.05%, and a NPV of 68%. The difference between the malignant and benign groups' ADC variables was statistically significant ( < 0.003). The ROC curve showed that the area under the curve is C = 0.718 with SE = 0.069 and 95% confidence interval from 0.548 to 0.852.

CONCLUSION

In our study, we demonstrated that diffusion MRI has limited diagnostic value in the assessment of viable tumor tissue after TACE with DEBs in cases of HCC.

摘要

目的

评估弥散加权磁共振成像(DW-MRI)在经动脉化疗栓塞术(TACE)联合药物洗脱微球(DEB)治疗后肝细胞癌(HCC)残留恶性肿瘤检测中的作用。

对象与方法

对60例行DEB经动脉肝化疗栓塞术的HCC患者进行对比前T1、T2、动态对比增强及呼吸触发DW-MRI(b值为0、400和800 s/mm²)检查。计算DW成像图像的灵敏度、特异度、阳性预测值(PPV)和阴性预测值(NPV)。利用受试者工作特征(ROC)曲线计算表观扩散系数(ADC),寻找最佳截断值。

结果

DW-MRI的灵敏度为77.1%,特异度为60.7%,PPV为71.05%,NPV为68%。恶性组与良性组的ADC变量差异具有统计学意义(P<0.003)。ROC曲线显示曲线下面积C = 0.718,标准误SE = 0.069,95%置信区间为0.548至0.852。

结论

在我们的研究中,我们证明了弥散MRI在评估HCC患者DEB-TACE术后存活肿瘤组织方面的诊断价值有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/79eac926f2eb/IJRI-29-195-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/42dc6553acfe/IJRI-29-195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/c2b11fd166b3/IJRI-29-195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/9866f44640a0/IJRI-29-195-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/79eac926f2eb/IJRI-29-195-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/42dc6553acfe/IJRI-29-195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/c2b11fd166b3/IJRI-29-195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/9866f44640a0/IJRI-29-195-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2912/6639864/79eac926f2eb/IJRI-29-195-g004.jpg

相似文献

1
Diagnostic accuracy of intermediate -value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads.药物洗脱微球经动脉化疗栓塞术后,中间值扩散加权成像检测残留肝细胞癌的诊断准确性
Indian J Radiol Imaging. 2019 Apr-Jun;29(2):195-200. doi: 10.4103/ijri.IJRI_383_18.
2
Apparent Diffusion Coefficient as a Noninvasive Biomarker for the Early Response in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Using Drug-eluting Beads.表观弥散系数作为载药微球经导管动脉化疗栓塞术治疗肝细胞癌早期疗效的无创性生物标志物。
Curr Med Imaging. 2022;18(11):1186-1194. doi: 10.2174/1573405618666220304141632.
3
Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization.钆塞酸二钠增强 MRI 和弥散加权成像在检测载药微球动脉化疗栓塞术后残留肝细胞癌中的价值。
Acad Radiol. 2021 Jun;28(6):790-798. doi: 10.1016/j.acra.2020.04.003. Epub 2020 May 13.
4
Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.多柔比星洗脱微球化疗栓塞术后即刻:表观弥散系数定量预测不可切除肝细胞癌的反应:一项初步研究。
J Magn Reson Imaging. 2015 Oct;42(4):981-9. doi: 10.1002/jmri.24845. Epub 2015 Feb 12.
5
Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?评估经动脉化疗栓塞术后局部肝细胞癌复发情况:扩散加权磁共振成像作为指标是否可靠?
J Magn Reson Imaging. 2008 Apr;27(4):834-9. doi: 10.1002/jmri.21316.
6
Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization.经动脉化疗栓塞术后采用弥散加权成像评估肝细胞癌存活情况的效用
Oncol Lett. 2014 Aug;8(2):831-836. doi: 10.3892/ol.2014.2228. Epub 2014 Jun 5.
7
Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging.利用磁共振扩散加权成像评估经动脉化疗栓塞术治疗肝细胞癌的疗效
Onco Targets Ther. 2017 Mar 16;10:1637-1643. doi: 10.2147/OTT.S115568. eCollection 2017.
8
Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.使用载药微球经动脉化疗栓塞治疗后肝细胞癌残余血流的超声造影评估:一项前瞻性研究
J Ultrasound Med. 2015 May;34(5):859-67. doi: 10.7863/ultra.34.5.859.
9
Quantitative evaluation of benign and malignant vertebral fractures with diffusion-weighted MRI: what is the optimum combination of b values for ADC-based lesion differentiation with the single-shot turbo spin-echo sequence?扩散加权 MRI 对良恶性椎体骨折的定量评估:单次激发快速自旋回波序列基于 ADC 值的病变鉴别最佳 b 值组合是什么?
AJR Am J Roentgenol. 2014 Sep;203(3):582-8. doi: 10.2214/AJR.13.11632.
10
Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.磁共振扩散加权成像的诊断价值:身体不同区域良恶性淋巴结的鉴别
Clin Imaging. 2015 Sep-Oct;39(5):856-62. doi: 10.1016/j.clinimag.2015.05.006. Epub 2015 May 22.

引用本文的文献

1
Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis.扩散加权成像及其定量表观扩散系数在经动脉化疗栓塞后诊断残留或复发性肝细胞癌中的应用:一项荟萃分析。
Cancer Imaging. 2020 Jan 6;20(1):3. doi: 10.1186/s40644-019-0282-9.

本文引用的文献

1
The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers.弥散加权成像(DWI)在预测肝细胞癌(HCC)局部区域治疗结果和评估反应中的作用:功能成像生物标志物的新时代。
Diagnostics (Basel). 2015 Nov 30;5(4):546-63. doi: 10.3390/diagnostics5040546.
2
MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization.药物洗脱微球经导管动脉化疗栓塞治疗肝细胞癌患者的MRI表现及进展时间预测
J Korean Med Sci. 2015 Jul;30(7):965-73. doi: 10.3346/jkms.2015.30.7.965. Epub 2015 Jun 10.
3
Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.
在接受阿霉素洗脱微球与索拉非尼联合治疗的肝细胞癌患者中,使用功能磁共振成像对肿瘤反应进行容积评估。
Eur Radiol. 2015 Feb;25(2):380-90. doi: 10.1007/s00330-014-3412-6. Epub 2014 Sep 17.
4
Diffusion weighted imaging in the liver.肝脏弥散加权成像。
World J Gastroenterol. 2010 Apr 7;16(13):1567-76. doi: 10.3748/wjg.v16.i13.1567.
5
Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.扩散加权成像在肝细胞癌化疗栓塞术后瘤周肿瘤复发MRI评估中的附加价值
J Magn Reson Imaging. 2009 Jul;30(1):153-60. doi: 10.1002/jmri.21818.
6
Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.磁共振弥散加权成像在评价肝癌化疗栓塞后反应中的作用。
Eur J Radiol. 2010 Jul;75(1):e9-14. doi: 10.1016/j.ejrad.2009.05.040. Epub 2009 Jun 18.
7
Post-treatment MRI findings of hepatocellular carcinoma.肝细胞癌的治疗后磁共振成像结果。
Diagn Interv Radiol. 2009 Jun;15(2):111-20.
8
Diffusion-weighted magnetic resonance imaging of pancreas tumours.胰腺肿瘤的扩散加权磁共振成像
Eur Radiol. 2009 Aug;19(8):1981-90. doi: 10.1007/s00330-009-1384-8. Epub 2009 Mar 24.
9
Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?评估经动脉化疗栓塞术后局部肝细胞癌复发情况:扩散加权磁共振成像作为指标是否可靠?
J Magn Reson Imaging. 2008 Apr;27(4):834-9. doi: 10.1002/jmri.21316.
10
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.功能磁共振成像在评估肝细胞癌患者化疗栓塞术后肿瘤反应中的作用。
J Vasc Interv Radiol. 2006 Mar;17(3):505-12. doi: 10.1097/01.RVI.0000200052.02183.92.